Country-specific medicine information

Medicine directory

Showing all available countries · Names and availability vary by country. Country coverage

Medicine names beginning with G.

Browse all available countries

35,008 records

Spain · Source reference 01198008

GLIVEC 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

COMPRIMIDO RECUBIERTO CON PELÍCULA / Novartis Europharm Limited, Novartis Farmaceutica S.A.

France · CIS 64936439

GLIVEC 100 mg, comprimé pelliculé

comprimé pelliculé / NOVARTIS EUROPHARM (IRLANDE)

Spain · Source reference 01198010

GLIVEC 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

COMPRIMIDO RECUBIERTO CON PELÍCULA / Novartis Europharm Limited, Novartis Farmaceutica S.A.

France · CIS 63485353

GLIVEC 400 mg, comprimé pelliculé

comprimé pelliculé / NOVARTIS EUROPHARM (IRLANDE)

Spain · Source reference 64544

GLIZOLAN 50 mg CAPSULAS DURAS

CÁPSULA DURA / Trinity Solutions S.L.

Canada · Source reference 100820

GLN-APREMILAST

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 100821

GLN-APREMILAST

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 101772

GLN-ATOVAQUONE

Suspension / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 103292

GLN-BILASTINE

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 100909

GLN-DAPAGLIFLOZIN

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 100910

GLN-DAPAGLIFLOZIN

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 98478

GLN-DIMETHYL FUMARATE

Capsule (Delayed-Release) / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 98479

GLN-DIMETHYL FUMARATE

Capsule (Delayed-Release) / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 106460

GLN-EDOXABAN

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 106461

GLN-EDOXABAN

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 106462

GLN-EDOXABAN

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 94824

GLN-EZETIMIBE

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 89563

GLN-GABAPENTIN

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 89564

GLN-GABAPENTIN

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 107149

GLN-NINTEDANIB

Capsule / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 107150

GLN-NINTEDANIB

Capsule / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 95870

GLN-OLMESARTAN

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 95871

GLN-OLMESARTAN

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 96608

GLN-OLMESARTAN HCTZ

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 96609

GLN-OLMESARTAN HCTZ

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 96610

GLN-OLMESARTAN HCTZ

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 103062

GLN-POSACONAZOLE

Tablet (Delayed-Release) / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 77316

GLN-TOPIRAMATE

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 77317

GLN-TOPIRAMATE

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.

Canada · Source reference 77318

GLN-TOPIRAMATE

Tablet / GLENMARK PHARMACEUTICALS CANADA INC.